Brian D. Stadinski, Ph.D. - Publications

Affiliations: 
2009 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Jones MC, Castonguay C, Nanaware PP, Weaver GC, Stadinski B, Kugler-Umana OA, Huseby ES, Stern LJ, McKinstry KK, Strutt TM, Devarajan P, Swain SL. CD4 Effector TCR Avidity for Peptide on APC Determines the Level of Memory Generated. Journal of Immunology (Baltimore, Md. : 1950). PMID 37093656 DOI: 10.4049/jimmunol.2200337  0.337
2023 Stadinski BD, Cleveland SB, Brehm MA, Greiner DL, Huseby PG, Huseby ES. I-A β56/57 polymorphisms regulate non-cognate negative selection to CD4 T cell orchestrators of type 1 diabetes. Nature Immunology. PMID 36807641 DOI: 10.1038/s41590-023-01441-0  0.521
2019 Stadinski BD, Blevins SJ, Spidale NA, Duke BR, Huseby PG, Stern LJ, Huseby ES. A temporal thymic selection switch and ligand binding kinetics constrain neonatal Foxp3 T cell development. Nature Immunology. PMID 31209405 DOI: 10.1038/s41590-019-0414-1  0.454
2018 Rowe JH, Delmonte OM, Keles S, Stadinski BD, Dobbs AK, Henderson LA, Yamazaki Y, Allende LM, Bonilla FA, Gonzalez-Granado LI, Celikbilek Celik S, Guner SN, Kapakli H, Yee C, Pai SY, et al. Patients with mutations reveal a role for human CD3γ in T diversity and suppressive function. Blood. PMID 29653965 DOI: 10.1182/Blood-2018-02-835561  0.411
2017 Rowe JH, Stadinski BD, Henderson LA, de Bruin LO, Delmonte O, Lee YN, Teresa de la Morena M, Goyal RK, Hayward A, Chiung-Hui H, Kanariou M, King A, Kuijpers TW, Soh JY, Neven B, et al. Abnormalities of T cell receptor repertoire in CD4(+) regulatory and conventional T cells in patients with RAG mutations: implications for autoimmunity. The Journal of Allergy and Clinical Immunology. PMID 28864286 DOI: 10.1016/J.Jaci.2017.08.001  0.394
2016 Wyss L, Stadinski BD, King CG, Schallenberg S, McCarthy NI, Lee JY, Kretschmer K, Terracciano LM, Anderson G, Surh CD, Huseby ES, Palmer E. Affinity for self antigen selects Treg cells with distinct functional properties. Nature Immunology. PMID 27478940 DOI: 10.1038/Ni.3522  0.384
2016 Stadinski BD, Shekhar K, Gómez-Touriño I, Jung J, Sasaki K, Sewell AK, Peakman M, Chakraborty AK, Huseby ES. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nature Immunology. PMID 27348411 DOI: 10.1038/Ni.3491  0.498
2016 Stadinski BD, Obst R, Huseby ES. A 'hotspot' for autoimmune T cells in type 1 diabetes. The Journal of Clinical Investigation. PMID 27183386 DOI: 10.1172/Jci88165  0.529
2014 Stadinski BD, Huseby ES. Identifying environmental antigens that activate myelin-specific T cells. Trends in Immunology. 35: 231-2. PMID 24820694 DOI: 10.1016/J.It.2014.04.004  0.321
2014 Stadinski BD, Trenh P, Duke B, Huseby PG, Li G, Stern LJ, Huseby ES. Effect of CDR3 sequences and distal V gene residues in regulating TCR-MHC contacts and ligand specificity. Journal of Immunology (Baltimore, Md. : 1950). 192: 6071-82. PMID 24813203 DOI: 10.4049/Jimmunol.1303209  0.504
2012 Huseby ES, Huseby PG, Shah S, Smith R, Stadinski BD. Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Frontiers in Immunology. 3: 64. PMID 22566945 DOI: 10.3389/Fimmu.2012.00064  0.343
2011 Stadinski BD, Trenh P, Smith RL, Bautista B, Huseby PG, Li G, Stern LJ, Huseby ES. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. Immunity. 35: 694-704. PMID 22101158 DOI: 10.1016/J.Immuni.2011.10.012  0.385
2011 Zhang L, Stadinski BD, Michels A, Kappler JW, Eisenbarth GS. Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice. Diabetes/Metabolism Research and Reviews. 27: 784-9. PMID 22069260 DOI: 10.1002/dmrr.1252  0.618
2011 Crawford F, Stadinski B, Jin N, Michels A, Nakayama M, Pratt P, Marrack P, Eisenbarth G, Kappler JW. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proceedings of the National Academy of Sciences of the United States of America. 108: 16729-34. PMID 21949373 DOI: 10.1073/Pnas.1113954108  0.679
2010 Stadinski BD, Zhang L, Crawford F, Marrack P, Eisenbarth GS, Kappler JW. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register. Proceedings of the National Academy of Sciences of the United States of America. 107: 10978-83. PMID 20534455 DOI: 10.1073/Pnas.1006545107  0.661
2010 Stadinski B, Kappler J, Eisenbarth GS. Molecular targeting of islet autoantigens. Immunity. 32: 446-56. PMID 20412755 DOI: 10.1016/j.immuni.2010.04.008  0.641
2010 Stadinski BD, Delong T, Reisdorph N, Reisdorph R, Powell RL, Armstrong M, Piganelli JD, Barbour G, Bradley B, Crawford F, Marrack P, Mahata SK, Kappler JW, Haskins K. Chromogranin A is an autoantigen in type 1 diabetes. Nature Immunology. 11: 225-31. PMID 20139986 DOI: 10.1038/Ni.1844  0.676
2006 Crawford F, Jordan KR, Stadinski B, Wang Y, Huseby E, Marrack P, Slansky JE, Kappler JW. Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Immunological Reviews. 210: 156-70. PMID 16623770 DOI: 10.1111/J.0105-2896.2006.00365.X  0.578
Show low-probability matches.